Correlation Between GlaxoSmithKline PLC and Neurotech International
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Neurotech International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Neurotech International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Neurotech International, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Neurotech International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Neurotech International. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Neurotech International.
Diversification Opportunities for GlaxoSmithKline PLC and Neurotech International
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between GlaxoSmithKline and Neurotech is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Neurotech International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurotech International and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Neurotech International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurotech International has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Neurotech International go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Neurotech International
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Neurotech International. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 2.6 times less risky than Neurotech International. The stock trades about -0.31 of its potential returns per unit of risk. The Neurotech International is currently generating about 0.43 of returns per unit of risk over similar time horizon. If you would invest 5.00 in Neurotech International on August 28, 2024 and sell it today you would earn a total of 1.90 from holding Neurotech International or generate 38.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Neurotech International
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Neurotech International |
GlaxoSmithKline PLC and Neurotech International Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Neurotech International
The main advantage of trading using opposite GlaxoSmithKline PLC and Neurotech International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Neurotech International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurotech International will offset losses from the drop in Neurotech International's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Neurotech International vs. FSA Group | Neurotech International vs. Tamawood | Neurotech International vs. Rea Group | Neurotech International vs. CSL |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |